Genetic engineering of T cell specificity for immunotherapy of cancer
- 24 December 2002
- journal article
- review article
- Published by Elsevier BV in Human Immunology
- Vol. 64 (1), 56-68
- https://doi.org/10.1016/s0198-8859(02)00730-9
Abstract
No abstract availableKeywords
This publication has 65 references indexed in Scilit:
- Retroviral Transduction of a T Cell Receptor Specific for an Epstein–Barr Virus-Encoded PeptideClinical Immunology, 2001
- Pharmacologic suppression of target cell recognition by engineered T cells expressing chimeric T-cell receptorsCancer Gene Therapy, 2000
- Impact of chimeric immune receptor extracellular protein domains on T cell functionGene Therapy, 1999
- The discovery of MHC restrictionImmunology Today, 1997
- Serial triggering of many T-cell receptors by a few peptide–MHC complexesNature, 1995
- New simplified molecular design for functional T cell receptorEuropean Journal of Immunology, 1993
- Immunologic recognition of malignant melanoma by autologous T lymphocytesCurrent Opinion in Oncology, 1993
- A Gene Encoding an Antigen Recognized by Cytolytic T Lymphocytes on a Human MelanomaScience, 1991
- The cytoplasmic domain of the T cell receptor ζ chain is sufficient to couple to receptor-associated signal transduction pathwaysCell, 1991
- Expression of chimeric receptor composed of immunoglobulin-derived V resions and T-cell receptor-derived C regionsBiochemical and Biophysical Research Communications, 1987